TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
TScan Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire November 12, 2025 Reached agreement with FDA on pivotal study design for TSC-101 following productive end of Phase 1 meeting Data from ALLOHA(TM) Phase 1 heme trial to be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition […]